A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2009-10-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study is designed to collect data on real world experience on use of Medrol in acute asthma in Indian patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

NCT00117338

Asthma

COMPLETED PHASE3

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

NCT00679263

Asthma

COMPLETED PHASE2

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)

NCT01502371

Asthma

COMPLETED PHASE2

Montelukast Back to School Asthma Study (0476-340)

NCT00461032

Asthma

COMPLETED PHASE3

Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)

NCT01566149

Asthma

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sequential enrollment

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Methylprednisolone Group

Oral Methylprednisolone Tablets

Intervention Type DRUG

Oral Methylprednisolone tablets given as per locally approved prescribing information

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oral Methylprednisolone Tablets

Oral Methylprednisolone tablets given as per locally approved prescribing information

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To be eligible for enrollment in this study, patients must be prescribed oral Medrol® tablets (4mg and 16 mg) for acute asthma as per the locally approved prescribing information. The prescription of Medrol® will be separated from the decision to include the patient in the study.
* Medrol® tablets, will be prescribed to the patient by the physician according to his/her usual practice. The decision to prescribe Medrol® tablet will necessarily precede and will be independent of the decision to enroll patient into the study. Only those patients who have been prescribed Medrol® tablets will be evaluated for their potential eligibility for the study
* Only those patients, who are ready and willing to sign an informed consent, will be included in the study
* Subject can be contacted through telephone

Exclusion Criteria

* Based upon history or physical exam in the emergency department (ED) or Clinic, subjects with known or suspected cause of pulmonary symptoms other than asthma, such as COPD, CHF, pneumonia, pulmonary embolism, or angioedema
* Any contraindication to Medrol tablet use. Contraindications of Medrol use are systemic fungal infections and known hypersensitivity to components

Eligible Sex

ALL

Accepts Healthy Volunteers

No